GeneDx Holdings Corp.
WGS
$106.65
-$1.70-1.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.81M | -6.53M | 5.44M | -8.31M | -29.17M |
| Total Depreciation and Amortization | 6.19M | 5.68M | 4.66M | 5.93M | 5.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.76M | 7.68M | -5.52M | 3.74M | 23.00M |
| Change in Net Operating Assets | -16.34M | 3.35M | -7.76M | -5.75M | -3.55M |
| Cash from Operations | 10.42M | 10.18M | -3.18M | -4.40M | -4.51M |
| Capital Expenditure | -2.37M | -6.13M | -3.05M | -646.00K | -1.35M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -33.20M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -786.00K | -3.28M | 2.53M | -7.11M | -21.35M |
| Cash from Investing | -36.35M | -9.41M | -519.00K | -7.76M | -22.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -853.00K | -911.00K | -1.53M | -707.00K | -528.00K |
| Issuance of Common Stock | 1.20M | 14.63M | 32.55M | 14.68M | 137.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 346.00K | 13.72M | 31.02M | 13.97M | -391.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.58M | 14.49M | 27.32M | 1.82M | -27.60M |